The objectives of this study were to investigate the effects of exogenous somatotropin on growth performance and carcass traits and on concentrations of somatotropin ( S T ) , IGF-I, insulin, glucagon, free fatty acids (FFA), and glucose in plasma of finishing Simmental beef heifers. Three treatment groups, which included 12 heifers each, received a subcutaneous injection of a slowly released recombinant bovine somatotropin (rbST) at two doses (320 and 640 mg, respectively) or a placebo at 2-wk intervals. Treatments began at an average BW of 286 kg and continued until the animals were slaughtered at approximately 520 kg. Heifers had ad libitum access t o corn silage and received 1.8 kgld of concentrate. A before-feeding blood sample was collected from the jugular vein immediately before and 1 wk after each injection during treatment. Treatment tended to increase ADG and to reduce energy consumption per kilogram of gain, whereas feed and energy intake were not altered. Dressing percentage and conformation did not seem to be affected by treatment. Treatment led to a dose-dependent reduction of fat tissue in carcass as well as in kidney fat and to a simultaneous increase of lean tissue ( P < .05).
Introduction
Treatment with somatotropin ( ST) improved ADG and feed efficiency ( FE) in bovine animals (Brumby, J. Anim. Sci. 1993 . 71:2721 -2731 somatotropin ( rbST)/kg BW (Moseley et al., 19923 . Specifically, the application of rbST enhanced protein synthesis in beef heifers (Eisemann et al., 1989) . There is some evidence that circulating IGF-I and protein percentage in carcass are positively correlated . The IGF-I concentrations in plasma were increased in heifers (McShane et al., 1989) and steers (Moseley et al., 1992) by daily treatment with rbST. Application of ST resulted in enhanced plasma levels in heifers (Kirchgessner et al., 1987; Sandles and Peel, 1987; McShane et al., 1989) . In addition, plasma concentrations of insulin and free fatty acids (FFA) are elevated in heifers treated with bST daily (Eisemann et al., 1986; McShane et al., 1989 ).
An effective increase in protein composition and a reduction in fat composition of carcass gain during ST treatment could be beneficial in finishing Simmental beef heifers, because this breed shows a pronounced increase in fat accretion in relation to protein accretion above a BW of approximately 300 kg. The purpose of this study was to investigate the effects of rbST on feed and energy intake, feed efficiency, daily gain, carcass composition, meat quality, and the endocrine system.
Materials and Methods
Animals and Preperiod. Forty-two German Simmental heifers, offspring of six bulls, were purchased at 54 k 2 d of age when BW was 84.6 f 3.5 kg. They were reared according to a standardized system (Schwarz et al., 1985a) . During the 112-d rearing period, the heifers had an ADG of 1,048 f 32 g and reached an average BW of 202 k 5.8 kg. After this the animals were acclimatized, during a period of 71 d, to the accommodation used for the experiments. A cubicle house divided into pens was used. Each pen contained six cubicles and was equipped with six electronically controlled feeding boxes to allow individual feed intake to be measured (Schwarz et al., 1985b) . During the preliminary period, corn silage was fed to appetite. The concentrates, which contained 58.3% soybean meal, 26.7% barley, 6.7% corn, and 8.3% minerals and vitamins, were restricted to a constant amount of 1.8 kg/d. The ADG was 1,183 f 38 €5
Treatment. Three groups (each 12 animals) from the 42 heifers described above were assigned to receive 320 (Group 2 ) or 640 mg (Group 3 ) of rbST (Somidobove, Elanco, Bad Homburg, FRG) or a placebo (Group 1 ). The doses were not adjusted to BW during the period of treatment. The doses were equal to approximately 80 pg-kg BW-l.d-I (Group 2 ) and 160 pg.kg BW-l-d-l (Group 3 ) at the beginning of the trial; by the end of the trial, the relative doses had declined to 44 and 88 pg.kg BW-l.d-I for the respective treatment groups. Injections were given into the ischiorectal fossa at 2-wk intervals. Treatments were administered from an average starting weight of 286 If: 2.5 kg until 1 wk before slaughter. The heifers were weighed each time that rbST was injected.
Feeding. The feeding system was the same as in the preliminary period. Corn silage was weighed and fed (allowing ad libitum access) once a day. Concentrate ( 1.8 kg, for composition see preliminary period) was divided daily into two equal portions. Feed and nutrient consumption were calculated according to refusals weighed every 2 d. Samples of corn silage were mixed from samples taken three times a week and combined for analysis every 4 wk, whereas samples of concentrate were taken from each batch. Dry matter determination and analyses of nutrients and starch were performed according to the methods of Schwarz and Kirchgessner (1990) . The ME was calculated based on the digestibilities of crude nutrients according to German feeding values for Z ET AL. ruminants (DLG, 1991) . The results of nutrient analyses and ME are presented in Table 1 .
Carcass Compositional Characteristics. The feeding experiment was finished at an average BW of 520 f 3.2 kg. Slaughter weight after feed deprivation for 2 24 h, carcass weight, dressing percentage ([carcass weighuslaughter weight] x 100)) and weights of kidney fat and the organs (liver, kidney, spleen, and pituitary) were recorded. Conformation (muscularity of hindlegs) and fatness were visually assessed according to the European classification system, described by letters from the acronym EUROP, with E for excellent, U, R, 0, and P for poor (EEC, 1982) . In this study E was equal to 5 and P was equal to 1. Fatness was scored from 1 (leanest) to 5 (fattest).
Primal cuts were defined by EEC reference (EEC, 1982) . Muscle and fat percentages were estimated based on the weights of some cuts and the composition of brisket and ribs as in previous work (Kogel et al., 1991) . Bone and tendon percentage made up the difference to 100%. Hindquarter (separated between 8th and 9th rib) was defined by the sum of the following cuts: leg, topside, rump, filled, sirloin, and wing rib. Moreover, fat content of longissimus muscle was determined, and marbling was scored from 1 (poor f a t ) to 5 (extremely fat). In addition pH was measured during the postmortem process after 1 and 24 h in the longissimus muscle.
Samples and Hormone Analysis. Before feeding, a single blood sample was collected by means of a Vacutainer@ tube (Greiner, Frickenhausen, FRG) from the jugular vein at 2-wk intervals during 16 wk before treatment and before and 1 wk after each rbST injection. After centrifugation at 4"C, plasma was separated and stored at -20°C until it was assayed.
Plasma samples were analyzed for ST, IGF-I, insulin, and glucagon using double-antibody RIA. Briefly, 5 pg of bovine insulin and glucagon (Novo Comp., Copenhagen, Denmark) were labeled with 500 pCi of 1251 in an iodogen-coated tube. First antibodies against bovine insulin and glucagon were raised in guinea pigs and provided sensitivities of 20 pg/tube for insulin and 50 pg/tube for glucagon, respectively. The separation of the antibody/antigen complex was achieved by a second antibody, which was raised in a sheep against guinea-pig immunoglobulins. The intraassay CV for glucagon was < 8% and interassay CV was < 10%. The intra-and interassay CV for insulin were < 10 and 15%, respectively. The ST (rbST lot 170 B, Eli Lilly, Greenfield, I N ) was labeled using chloramine T and 500 pCi of 1251. First antibody, raised in rabbits against pituitary extracted ST (USDA-bGH-B-I), provides a standard curve covering a range of .1 to 2 ng/tube. Antirabbit globulin was raised in sheep and used as the second antibody. The intraassay CV was < lo%, and the interassay CV was < 12%. Analysis of IGF-I requires extraction to avoid interference from binding proteins. Therefore, samples and standard (synthetic IGF-I/87/518, National Institute for Biological Standards and Control, U.K.) were extracted with aciaethanol (Daughaday et al., 1980) . The IGF-I ( 5 pg of recombinant IGF-I, Monsanto, St. Louis, MO) was labeled using lactoperoxidase and 500 pCi of 1251. The IGF-I specific antibody (provided by P. Gluckman, Auckland, New Zealand) gave a standard curve ranging from 2 1 to 2,088 ng/mL. A second antibody (antirabbit globulin raised in sheep) and polyethylene glycol ( 12 5% weight/volume) were used for the separation of the antibody/antigen complex. The intra-and interassay CV were < 10 and 15%, respectively.
Plasma glucose was determined photometrically using a commercial enzyme assay (GOD-PAP trinder, Sigma Diagnostics, Deisenhofen, FRG). Free fatty acids were assayed using a commercial kit based on enzyme reactions [Acyl-coenzyme A (CoA)I synthetase, Acyl-CoA oxidase, Peroxidase) with a photometric determination. Intraassay CV for glucose and FFA were < 8%.
Statistics. Data were analyzed with analysis of variance using the GLM procedure of SAS ( 1987) . The data are presented at least squares means. Significances are indicated by different superscripts. A nested model (Gill, 1978) was used for data on growth and carcass performance. The model included treatment, pen, and pedigree, and interactions were tested.
Significant differences between means were tested by the Student-Newman-Keuls test. Endocrine and metabolic data were analyzed by the use of two models. The first model considered effects of treatment, time, and animal; interactions were not significant. Trial was subdivided into pretreatment period and four periods during treatment, thus providing the ability to compare groups within periods. The second model was used to calculate least squares means (by time and animal) within treatment (Figures 1 and 2 ). Successive periods (pretreatment, four periods during treatment) in the trial were compared with t-tests.
Results

Growth Performance and Carcass Characteristics
Growth performance data are shown in Tables 2 and 3. Data were averaged over the time of trial. Treatment with rbST tended to increase ADG by 9 and 11% in Groups 2 and 3, respectively ( P < .08 between Groups 1 and 3). Application of rbST shortened the finishing period, and the final BW was slightly higher in treated animals. Total feed consumption, consumption of corn silage, and intake of N and ME were not significantly affected by treatment. However, ME consumption per kilogram of gain tended to be reduced in Group 3 ( P < .08) and was reduced ( P < .02) in Group 2 compared with controls.
Carcass composition and characteristics of meat quality are shown in Tables 4, 5, and 6. Carcass weight and dressing percentage were not altered by rbST treatment. Conformation class was reduced slightly in animals in Group 3, whereas hindquarter percentage was increased in Group 3 ( P < .05).
Fatness class was decreased significantly in Groups 2 and 3 compared with controls. Similarly, kidney fat was reduced by up to 10.8 kg by rbST treatment. These shifts in fat content could be observed in lean and fat tissue percentages of the carcass as well (Table 5 ). Lean tissue percentage was increased in Groups 2 and 3 compared with Group 1 ( P < .01).
Conversely, fat tissue percentage was reduced by 7.4% in Group 3 and by 3.7% in Group 2 compared with Group 1. Consequently, these changes were reflected in 1ean:fat tissue ratio. Effects on bone were not found.
The rbST treatment reduced intramuscular fat content and the marbling scores of the longissimus muscle (Table 6 ). Both variables were changed significantly in Group 3 compared with controls, whereas values in Group 2 were lower, but not significantly so. The pH of the muscle at different times after slaughter was not influenced in treated animals.
The weights of organs are presented in Table 7 . Liver weight was increased significantly in both treated groups, whereas spleen weight remained unchanged. Kidney weight and pituitary weight were significantly higher in Group 3 than in Group 1.
Endocrine and Metabolic Response
The mean concentrations of hormones, FFA, and glucose for different periods of the trial are presented in Table 8 , and the course of mean plasma concentrations for samplings are in Figures 1 (ST and IGF-I) and 2 (insulin and glucagon). Starting treatment with rbST tended to increase ST, because prelevels were significantly lower than those in controls. The concentrations of ST were elevated significantly after 70 d of treatment and tended to decline toward the end of treatment; the decline was more pronounced in Group 2. The differences in the last period of treatment were not significant due to high SE.
There was an obvious increase in IGF-I due to rbST injections. The IGF-I profiles showed rbST-dependent two-and threefold increases for the 320-and 640-mg dose groups, respectively, in comparison with the controls. Despite significantly higher pretreatment concentrations of IGF-I in controls, a dose-dependent increase in IGF-I concentrations was evident. Concentrations of IGF-I were increased immediately after starting treatment. Therefore, differences compared with controls were already significant in the first period of treatment. Additionally, there were obvious injection-dependent dynamics in IGF-I concentrations in treated animals; IGF-I concentrations were higher in samples taken 7 d after each injection than in samples taken 14 d after each injection (before the next injection).
Insulin concentrations were considerably higher in treated groups than in the control group, although centrations were observed, although the increases were not always significant. Additionally, the dynamics of insulin concentrations in treated groups resembled those of IGF-I; higher values could be observed on d 7 after injection than in the preinjection samples, GROWTH-PROMOTING EFFECTS OF SOMATOTROPIN concentrations in controls increased as well. Pretreatment insulin concentrations were elevated in Group 2. However, concentrations in treated groups were already significantly elevated in the first period of treatment. Dose-dependent increases in insulin con- for insulin and glucagon in plasma before and during recombinant bovine somatotropin (rbST) (Group 1, controls; Group 2, 320 mg of rbST; Group 3, 640 mg of rbST; successive periods within groups are statistically compared; * P < .05, * * P < .01, * * * P < .001). this being more obvious in the high-dose group (Figure 2A ). Glucagon concentrations declined over the trial periods in all three groups. Analyses of differences between groups revealed significant, but moderate, differences in pretreatment concentrations and those during treatment ( Figure 2B ).
Group
Information about metabolism is provided by the concentrations of FFA and glucose. The FFA concentrations increased in all three groups during the trial; however, the increase was greater in rbST-treated heifers than in controls. Pretreatment FFA concentrations were similar in all three groups. Treatment caused significant increases in Group 3 compared with Group 2 and the controls; concentrations for Group 2 did not differ significantly from the controls. Glucose concentrations were only significantly elevated in Group 3 during first period of treatment, and the magnitude of increase was small.
Discussion
Growth Performance and Carcass Characteristics
Results of bST treatment in heifers have been published by several authors. However, injection intervals (usually daily doses of bST), type of bST (pituitary or recombinant), test period, animal weights, and diet have to be considered in interpreting the results (Brumby, 1959; Fabry et al., 1987; Sejrsen et al., 1986; Kirchgessner et al., 1987; Sandles and Peel, 1987; McShane et al., 1989; Grings et al., 1990) . Daily administration of bST a t doses ranging from 25 to 600 pg.kg BW-'.d-I in young heifers that weighed between 70 and 109 kg increased ADG by 7.1 to 10.8'36, whereas feed efficiency was improved by 2 to 8% compared with control animals. Feed intake was increased by 2 to 6% (Brumby, 1959; Sejrsen et al., 1986; Kirchgessner et al., 1987; Sandles and Peel, 1987) . In Holstein heifers of 295 kg BW. daily injection of rbST increased ADG by 9.8 and 7.7% and improved feed efficiency by 7.7 and 10.2% (Grings et al., 1989) . Fabry et al. (1987) reported a 23.5% increase in ADG and a 20.3% improvement in FE in finishing beef heifers receiving a daily dose of 50 pg of pituitary bST.
Consistent with these results, we observed an increase in ADG when averaged over the entire test period in rbST-treated finishing beef heifers. Feed tended to be used more efficiently in treated animals, because energy consumption per kilogram of gain was reduced in both treated groups, although less reduced in the high dose group. This might have been because daily DMI and energy intake were slightly reduced in the low-dose group for unknown reasons. Johnsson et al. (1985) explained the improved feed conversion rate in ST-treated female lambs with a greater growth rate. For our study, we concluded that energy consumption per kilogram of gain was improved by an elevated growth rate and, in view of the carcass data, by the accretion of more protein a t the expense of fat.
Although no dose-response could be observed in terms of energy consumption per kilogram of gain, dose positively affected fat and lean percentage in the carcass as well as kidney fat. In agreement with the present trial, rbST treatment improved carcass composition up to a dose of 300 pg.kg BW-l.d-l in finishing beef steers (Moseley et al., 1992) . Furthermore, backfat thickness was reduced in a linear manner with increasing dose of rbST (Moseley et al., 1992) . Therefore, a biological plateau might not have been attained in reducing carcass fat in the present study. Based on the marked increase in lean percentage, we aGroup 1 = controls, Group 2 = 320 mg of rbST, Group 3 = 640 mg of rbST. bSE = overall standard error. XJDifferent superscripts indicate significant differences ( P < .05 ).
assume that protein accretion was elevated in the present trial. In agreement, Eisemann et al. (1989) observed stimulated protein synthesis and decreased leucine oxidation associated with lower plasma urea nitrogen in bST-treated beef steers. Classification of the carcass based on the EEC classification grid indicated a reduction of fat, whereas conformation was not changed by rbST treatment. Hindquarter percentage was slightly, but significantly, increased in the high dose group. Early et al. (1990b) reported no effects of rbST on weights and growth of individual muscles from the hindquarter. This indicates that rbST modifies the composition of cuts but not the relative weight of cuts within the carcass. Furthermore, dressing percentage was little affected in the present trial implying no changes in the proportion of carcass to noncarcass components. In young heifers, increases in dressing percentage were absent or slight (Sejrsen et al., 1986; Kirchgessner et al., 1987; Sandles and Peel, 1987) . In contrast, a reduction of 2 to 3% in dressing percentage was reported for heavier heifers and steers (Fabry et al., aGroup 1 = controls, Group 2 = 320 mg of rbST, Group 3 = 640 mg of rbST.
bST = somatotropin; IGF-I = insulin-like growth factor I; FFA = free fatty acids. CSE = overall within group and variable standard error. X,Y,ZDifferent superscripts indicate significant differences between groups ( P < ,051.
1987; Wagner et al., 1988) . As far as noncarcass components are concerned, higher weights of liver, kidney, and pituitary in treated animals are in agreement with previous studies (Sandles and Peel, 1987; Moseley et al., 1992) . The application of rbST to reduce the fat content in the carcass raises the question of possible effects on fat within muscles. In the present trial, intramuscular fat content as well as marbling scores of longissimus muscle were reduced in a dose-dependent manner. Taking into consideration that some fat within the muscle is desirable, the high dose of rbST might have caused a reduction of fat content below a desirable level.
Endocrine and Metabolic Responses
Concentrations of ST were slightly elevated in treated groups and declined toward the end of treatment, possibly indicating a slow release from the injection site and an adjusted clearance rate after application of exogenous ST. Peak values in the controls may be explained by the pulsatile secretion pattern of ST observed in growing cattle (Schams et al., 1988) or dairy cows (Schams et al., 1991a) . Stimulation of IGF-I secretion, presumably in the liver, is shown clearly because plasma IGF-I concentrations were significantly increased and constantly higher between two injections ( 7 d after injections). A comparable clear increase of IGF-I concentrations was observed in two breeds of dairy cows after treatment with a slowly released preparation of rbST (Schams et a] ., 1991b). A positive energy balance, as shown in the present trial by growth and carcass data, enhances the responsiveness of the liver to ST and, thus, the IGF-I secretion in the liver (Breier et al., 1987; Elsasser et al., 1989) . Elevated plasma IGF-I concentrations are assumed t o be related to enhanced protein accretion and to our findings of improved muscle percentage at the expense of fat in the carcass. Douglas et al. (1991) observed reduced protein loss in lambs after administration of human recombinant IGF-I. The physiological explanation may be an improved protein synthesis and inhibition of protein breakdown documented for L6 myoblasts (Ballard et al., 1986) . Furthermore, enhanced IGF-I concentrations might have caused enhanced protein accretion after application of ST in other studies (Pel1 and Bates, 1987; Eisemann et al., 1989) .
Exogenous ST is expected to affect adipose tissue directly. Lipogenesis was inhibited in ovine adipose tissue (Sinnett-Smith and Wooliams, 1988) . Moreover, bovine ST had lipolytic activity as an intrinsic property of the molecule, which might be activated after modification of the molecule (Hart et al., 1984) . Increased FFA concentrations have been reported after daily bST treatment of heifers (Eisemann et al., 1986; McShane et al., 1989) and dairy cows (Schams et al., 1991b) . In agreement with these results, we found enhanced concentrations of FFA in treated animals, in particular in the high-dose group, suggesting a lipolytic activity of ST. Increasing FFA concentrations over time in the controls may be explained by high body content of fat; turnover of fat tissue led to higher FFA concentrations in the plasma. In terms of adipose tissue, high concentrations of insulin should have favored lipogenesis rather than lipolysis. Insulin is believed to promote lipid deposition by increasing adipocyte membrane permeability and stimulating adipose lipoprotein lipase in ruminants (Prior and Smith, 1982) as well as stimulating lipogenesis in bovine adipose tissue (Etherton and Evock, 1986) . In fact, a high percentage of fat tissue was only observed in the carcasses of controls, whereas fat tissue percentage in carcass was reduced in treated animals. This situation is characterized by high levels of insulin and blunted insulin sensitivity of adipose tissue. In ST-treated growing heifers, plasma insulin concentrations were elevated and were associated with reduced lipid deposition (Eisemann et al., 1986; McShane et al., 1989) . Etherton et al. (1987) speculated that ST in pigs blocks insulin action within the intracellular enzyme cascade after binding of insulin to its receptor. This kind of insulin insensitivity may cause enhanced insulin concentrations. Furthermore, ST may elicit insulin secretion. The dynamics of insulin in the present study, in Group 3 particularly, characterized by higher values between two injections might indicate a relationship between ST and insulin.
As far as glucagon was concerned, concentrations were not altered by rbST treatment and declined consistently during the period of treatment in all groups. In contrast, De Boer et al. (1991) reported increased glucagon concentrations in dairy cows that received daily injections of rbST. A contradictory study of De Boer and Kennelly (1988) revealed no changes in glucagon concentrations during rbST treatment. Glucagon is expected to be an energy-mobilizing hormone. It stimulates gluconeogenesis and augments the hepatic extraction of amino acids and induced lipolysis . A lipolytic effect of glucagon remains questionable because FFA and glucagon were negatively correlated (Bassett, 1971 ). Supplemental energy resulted in significantly lower concentrations of glucagon and growth hormone (Ostaszewski et al., 1990) . We conclude from the decreasing glucagon concentrations that energy balance was improving in all animals during the trial.
Glucose concentrations were affected very little by rbST treatment in our study. This can be explained by an impaired clearance of glucose and(or) an increase in hepatic glucose output (Gopinath and Etherton, 1989) .
Implications
According to the beef market in Germany, carcasses from heifers are considered inferior to carcasses derived from bulls. Administration of recombinant bovine somatotropin using a slowly released preparation is a suitable technique to alter carcasses from beef heifers, thus providing a desirable carcass in terms of degree of fatness and meat quality. Consequently, profitability of heifer beef production is expected to improve.
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